Health
Eyepoint's Setback in Age-Related Blindness Trial
Eyepoint, a company developing treatments for age-related blindness, disclosed that its Phase 3 trial did not meet the primary goal.
Coverage timeline — 1 article
STAT News
Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell short of its primary goal
2026-08-18 13:25 UTC